ACE inhibitors reversed the beneficial effects on tumor growth, but AT1 receptor blockade did not, suggesting that the effects of ACE overexpression were not dependent of Ang II/AT1 receptor signaling [149]. This evidence concerns the gene AGTR1 and neoplasm.